|
ADVANCED COLORECTAL CANCER
DRUG |
Drug for advanced colorectal cancer gets marketing nod in Canada
Erbitux (Cetuximab) injection as a treatment for metastatic colorectal
cancer.
|
|
|
|
|
|
BY OUR PHARMA CORRESPONDENT
18 September,2005: The Canadian drug regulator, Health Canada's Biologics and Genetic Therapies Directorate has approved Erbitux
(Cetuximab) injection as a treatment for metastatic colorectal
cancer.
Erbitux has been approved for use in combination with irinotecan in the treatment of patients with epidermal growth factor receptor (EGFR) - expressing, metastatic colorectal cancer who are refractory to other irinotecan-based chemotherapy, and as single agent therapy for patients who are intolerant to irinotecan-based chemotherapy, Bristol-Myers Squibb Canada and ImClone Systems Incorporated announced here.
Erbitux targets metastatic colorectal cancer cells expressing epidermal growth factor receptors (EGFR) on their surface. In Canada, an estimated 19,100 people are diagnosed with colorectal cancer every year. Half of these patients have metastatic disease, or cancer that has spread to other organs, at the time of diagnosis. EGFR is expressed in over 80 per cent of colorectal cancer tumours.
BY OUR PHARMA CORRESPONDENT |
|
|
 |
|
RELATED CANCER STORIES
All
cancer headlines
Drug for advanced colorectal cancer gets marketing nod in Canada
18 September,2005
Advanced prostate cancer therapy Provenge seeks marketing nod in US
18 September,2005
New kidney cancer drug seeks EU nod
13 September,2005
Breast cancer drug Aromasin approved in Europe: Pfizer
15 Sep, 2005
Lung cancer vaccine trials promising: Introgen
13 September,2005
Rituxan, cancer drug can treat rheumatoid arthritis
2 September, 2005
Novartis’ drug for breast cancer recurrence to be given priority review in US
31 August, 2005
New cancer combo therapy results
positive: OXiGENE
25 August, 2005
Cell Therapeutics to seek approval for lung cancer therapy in US and Europe
25 August, 2005
Aspirin stops colon cancer, but may trigger bleeding
24 August, 2005
Skin disease drug turns into anti-tumor therapy for cancer
22 August, 2005
"Breast cancer chances higher due to fried chips"
22 August, 2005
Pfizer files NDA for Sutent in US
13th August,2005
Alcohol linked cancers: Acetaldehyde in spot light
10 August, 2005
Chemokine gets US patent for novel cancer drug
20 June, 2005
Prohibitive costs mar cancer therapy
15 July, 2005
Viruses
may help cure cancer by killing cancer cells
CALGARY, Alberta, June 28
Cervical
Cancer detector may improve on Pap Smears
CHERRY HILL, N.J., June 28
Novartis has better breast cancer treatment
Toronto, Ontario, April 11, 2005
Roche, Novartis lead on novel cancer therapies
23 July, 2005
Pfizer's
investigational drug reduces tumor
growth
14 May, 2005
|
|
|
|
|
